Last Updated On 1/27/2026 1:27:03 AM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| Company: Foresight Diagnostics |
| Recipient: You |
| Company: Resero Bio |
| Recipient: You |
|
| Stock and Other Ownership Interests |
| Company: CiberMed |
| Recipient: You |
| Company: Foresight Diagnostics |
| Recipient: You |
| Company: Perception Medicine |
| Recipient: You |
| Company: Resero Bio |
| Recipient: You |
|
| Honoraria |
| Company: Chugai Pharma |
| Recipient: You |
|
| Consulting or Advisory Role |
| Company: AstraZeneca |
| Recipient: You |
| Company: Foresight Diagnostics |
| Recipient: You |
| Company: Gritstone Bio |
| Recipient: You |
| Company: Natera |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: AstraZeneca |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| Please describe: Royalties from Roche for patent licensing fees |
| Recipient: You |
| Please describe: Royalties from Foresight Diagnostics for patent licensing fees |
| Recipient: You |
| Please describe: Royalties from Natera for patent licensing fees |
| Recipient: You |
| Please describe: Royalties from Resero Bio for patent licensing fees |
| Recipient: You |
| Please describe: Patent filings on cancer biomarkers assigned to Stanford University |
| Recipient: Your Institution |
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| Company: Foresight Diagnostics |
| Recipient: You |
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
|
| Open Payments URL: https://openpaymentsdata.cms.gov/physician/937688/summary |
|